MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

495663

Report Date :

05.03.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

JUBILANT LIFE SCIENCES LIMITED (w.e.f.01.10.2010)

 

 

Formerly Known As :

JUBILANT ORGANOSYS LIMITED

 

 

Registered Office :

Bhartiagram, Gajraula, Jyotiba Phoolay Nagar – 244223, Uttar Pradesh

Tel. No.:

91-5924-252351-60

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

21.06.1978

 

 

Com. Reg. No.:

20-004624

 

 

Capital Investment / Paid-up Capital :

INR 159.300 Million

 

 

CIN No.:

[Company Identification No.]

L24116UP1978PLC004624

 

 

IEC No.:

0588001651

 

 

GSTN :

09AABCV0200H1ZU

 

 

TIN No.:

09459401916

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AABCV0200H

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Subject is a global Pharmaceutical and Life Sciences player engaged in manufacture and supply of Generics (Including Active Pharmaceuticals Ingredients (APIs) and Solid Dosage Formulations) and Life Science Ingredients (Including Proprietary Products and Exclusive Synthesis, Nutrition Ingredients and Life Sciences Chemicals). (Registered Activity)

 

 

No. of Employees :

6500 (Approximately)

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Status :

Excellent

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 1978 and is engaged in manufacturing and supplying of Generics (Including Active Pharmaceuticals Ingredients (APIs) and Solid Dosage Formulations) and Life Science Ingredients (Including Proprietary Products and Exclusive Synthesis, Nutrition Ingredients and Life Sciences Chemicals).

 

As per the quarterly results of December 2017, the company has achieved sales turnover of INR 20677.6 million along with fair profitability margin of 10.29%.

 

For the financial year ended 2017, the company has reported a decline in its revenue as compared to the previous year but has maintained average profit margin at 3.03% during the year under the review.

 

The company’s healthy financial profile is reflected by its sound solvency indicators due to adequate net worth base along with above average liquidity position

 

Rating also reflects company’s well established track record of business operations backed by well diversified business profile and vast experience of promoters in pharmaceutical segment.

 

The company has its share price trading at around INR 850 on BSE as on March 5, 2018 as against the Face Value (FV) of INR 1.

 

However, rating strength partially offset by vulnerability of its operating margin to volatility in raw material price and working capital intensive operations.

 

Business is active. Payment seems to be regular.

 

In view of aforesaid, the company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Commercial Paper = A1+

Rating Explanation

Very strong degree of safety and carry lower credit risk

Date

28.04.2017

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 05.03.2018.

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION DENIED

 

Management Non-Cooperative (Tel. No.: 91-120-4361000)

 

 

LOCATIONS

 

Registered Office / Factory 1 :

Bhartiagram, Gajraula, Jyotiba Phoolay Nagar – 244223, Uttar Pradesh, India

Tel. No.:

91-5924-252351-60

Fax No.:

91-5924-252352

E-Mail :

ajay_krishna@jubilantorganosys.com

ajay_krishna@jubl.com

investors@jubl.com

pradeep_kp@jubl.com

Website :

http://www.jubilantorganosys.com

http://www.jubl.com

 

 

Corporate Office :

Plot No. 1A, Sector–16-A, Noida–201301, Uttar Pradesh, India.

Tel. No.:

91-120-4361000

Fax No.:

91-120-4234881/ 84/ 85/ 87/ 95/ 96

E-Mail :

investors@jubl.com

support@jubl.com

 

 

Factory 2 :

56, Industrial Area, Nanjangud, District Mysore - 571302, Karnataka, India

Tel. No.:

91-8221228402-08

Fax No.:

91-8221228410-11

 

 

Factory 3 :

Block No. 133, P. O. Samlaya, Savli Jarod Road, Taluka Savli, Vadodara–391520, Gujarat, India

Tel. No.:

91-2667-251361/ 251563-4

Fax No.:

91-2667-251305

 

 

Factory 4 :

Sikanderpur Bhainswal Bhagwanpur, Roorkee, District Haridwar, Uttrakhand, India

Tel. No.:

91-332-235161-66

Fax No.:

91-332-235169

 

 

Factory 5 :

N-34, Additional Ambernath,  MIDC, Anand Nagar, Ambernath - 421506, Maharashtra, India

Tel. No.:

91-251-2620437/ 438

Fax No.:

91-251-2620439

 

 

Factory 6 :

Plot No.5, Vilayat GIDC, Taluka Vagra, Bharuch – 392012, Gujarat, India

Tel. No.:

91-2641-281500 (30 Lines)

Fax No.:

91-2641-281515

 

 

Factory 7 :

Village Nimbut, Railway Station, Nira. Tal-Baramati, District Pune, Pune-412102, Maharashtra, India

 

 

International Manufacturing Facilities :

Quebec

Add : Jubilant DraxImage, Inc

         16751, TransCanada Highway, Kirkland (Montreal), Québec, Canada H9H 4J4

Tel. : 91-514- 630 7030

Fax : 91-514 -694 9295

 

Spokane

Add : Jubilant HollisterStier LLC

         3525, N. Regal, Spokane, Washington 99207, USA

Tel. : 91- 509 -489 5656

Fax : 91- 509 -484 4320

 

Salisbury

Add : Jubilant Cadista Pharmaceuticals

         207 Kiley Drive, Salisbury, Maryland 21801, United State of America

Tel. : 91-410-8608500

Fax : 91-410-8608719

 

 

R and D Facilities :

Located at:

 

UTTAR PRADESH (CENTRAL R&D)

 

·         C-26, Sector 59, Noida - 201 301, India

 

·         D-12, Sector 59, Noida - 201 301, India

 

·         C- 46, Sector 62, Noida - 201 301, India

 

UTTAR PRADESH (GAJRAULA R&D)

 

Bhartiagram, Gajraula - 244 223, District Jyotiba Phoolay Nagar, India

 

KARNATAKA (NANJANGUD R&D)

 

51-56, KIADB Industrial Area, Nanjangud, District Mysore - 571302, Karnataka, India

 

KARNATAKA

 

Jubilant Biosys Limited

Drug Discovery Centre No.17, Industrial Suburb 2nd Stage Industrial Area Yeshwantpur, Bengaluru- 560022, Karnataka, India

 

 

Branch Office 1:

304-305, Doshi Chambers Opp. United Insurance Bldg. Bashir Bagh, Hyderabad - 500 029, Telangana, India

Tel. No.:

91-40-23227019/ 22327704

Fax No.:

91-40-23227213

 

 

Branch Office 2 :

WW-01, Rohtas Golf Link Apartments 98, Park Road, Lucknow - 226 001
Uttar Pradesh, India

Tel. No.:

91-522-2235148

Fax No.:

91-522-2238739

 

 

Branch Office 3 :

2nd Floor, JVL Plaza 501, Anna Salai, Teynampet Chennai - 600 018, Tamil Nadu, India

Tel. No.:

91-44-24349147/ 24348556- 5184

Fax No.:

91-44-24335875

 

 

Branch Office 4 :

2nd  Floor, Shah Sultan Complex 17, Cunningham Road, Bangalore - 560 052, Karnataka, India

Tel. No.:

91-80-22268137/ 22284418

Fax No.:

91-80-22203218

 

 

Branch Office 5 :

Transocean House, 1st Floor, Lake Boulevard, Hiranandani Business Park, Powai, Mumbai - 400 076, Maharashtra, India

Tel. No.:

91-22-40316900

Fax No.:

91-22-40316999

 

 

Branch Office 6:

225/5/1A, Pawar Complex Above Prince Restaurant Hadapsar, Pune - 411 028, Maharashtra, India

Tel. No.:

91-20-26992395

Fax No.:

91-20-26993896

 

 

Branch Office 7 :

402 Samrudhi Opposite Old Gujarat High Court Lane, Near Satar Paluk Society, Ahmedabad - 380014 Gujarat, India

Tel. No.:

91-79-27541190/ 27545564

Fax No.:

91-79-27541242

 

 

Branch Office 8 :

2nd Floor, Rawdon Chambers Sarojni Naidu Sarni 11A, Rawdon Street, Kolkata- 17, West Bengal, India

Tel. No.:

91-33-22871178/ 22872170

Fax No.:

91-33-22872170

 

 

DIRECTORS

 

AS ON 31.03.2017

 

Name :

Mr. Sridhar Srinivasan

Designation :

Director

Address :

D-905, Ashok Towers, Dr. S S Road, Parel, Mumbai - 400012, Maharashtra, India 

Date of Birth/Age :

M. Tech (Chem Engg.)

Date of Appointment :

15.06.2013

DIN No.:

00004272

 

 

Name :

Mr. Ashok Misra

Designation :

Director

Address :

68, Adarsh Vista, Basanvan Nagar Main Road, Vibhuthipura, Bangalore -  560037, Karnataka, India

Date of Birth/Age :

67 years

Qualification :

B. Tech. in Chemical Engineering

Date of Appointment :

15.09.2014

DIN No.:

00006051

 

 

Name :

Mr. Shyam Sunder Bhartia

Designation :

Director

Address :

27, Claymore Road, # 04-02 The Claymore, Singapore 229544

Date of Appointment :

21.06.1978

DIN No.:

00010484

 

 

Name :

Mr. Hari Shankar Bhartia

Designation :

Managing Director

Address :

2, Amrita Shergill Marg, New Delhi -  110003, India

Date of Appointment :

01.11.1983

DIN No.:

00010499

 

 

Name :

Mr. Priyavrat Bhartia

Designation :

Director

Address :

19, Friends Colony (West), Delhi – 110065, India

Date of Appointment :

23.05.2017

DIN No.:

00020603

 

 

Name :

Vivek Mehra

Designation :

Director

Address :

B-314, New Friends Colony, New Delhi – 110065, India

Date of Appointment :

23.05.2017

DIN No.:

00101328

 

 

Name :

Sushil Kumar Roongta

Designation :

Director

Address :

D - 91, DLF Pinnacle, DLF Phase - V, Opposite DLF Golf Course, Gurugram – 122009, Haryana, India

Date of Appointment :

23.05.2017

DIN No.:

00309302

 

 

Name :

Sudha Pillai

Designation :

Director

Address :

D-241, Second Floor, Sarvodaya Enclave, New Delhi – 110017, India

Date of Appointment :

03.09.2013

DIN No.:

02263950

 

 

Name :

Arjun Shanker Bhartia

Designation :

Director

Address :

House No.- 2 Amrita Shar Gill Marg, New Delhi – 110003, India

Date of Appointment :

23.05.2017

DIN No.:

03019690

 

 

Name :

Mr. Pramod Yadav

Designation :

Additional Director

Address :

5191, ATS One Hamlet, Sector 104, Noida – 201304, Uttar Pradesh, India

Date of Appointment :

01.04.2017

DIN No.:

05264757

 

 

KEY EXECUTIVES

 

Name :

Mr. Rajiv Chandrakant Shah

Designation :

Company Secretary

Address :

B-401, Indraprasth 3, Opposite Dhananjay Bungalows, Anandnagar Road, Satellite Ambawadi Vis Tar, Ahmedabad -  380015, Gujarat, India

Date of Appointment :

16.02.2015

PAN No.:

ACKPS8874L

 

 

Name :

Mr. Rajagopal Sankaraiah

Designation :

Chief Finance Officer

Address :

B4/11, DLF Phase – I, Gurugram – 122002, Haryana, India

Date of Appointment :

01.04.2014

PAN No.:

AAVPS4387H

 

 

Name :

Shyam S Bhartia

Designation :

Chairman

 

 

Name :

Dr. Ashutosh Agarwal

Designation :

Chief Scientific Officer [Chemicals and Life Science Ingredients]

Qualification:

M.Sc., Ph.D.

 

 

Name :

Ajay Khanna

Designation :

Group Ombudsman and Chief Strategic & Public Affairs

 

 

Name :

Dr. Raju Mistry

Designation :

Chief Human Resources Officer

 

 

Name :

Dr. Rajesh Kapoor

Designation :

Chief of Quality

 

 

Name :

Siddhartha Pahwa

Designation :

Chief of Supply Chain

 

 

Name :

GP Singh

Designation :

CEO Jubilant Pharma

 

 

Name :

Pramod Yadav

Designation :

Co-CEO Life Science Ingredients

 

 

Name :

Rajesh Srivastava

Designation :

Co-CEO Life Science Ingredients

 

 

Name :

Steven Hutchins

Designation :

President Drug Discovery Solutions

 

 

MAJOR SHAREHOLDERS

 

AS ON 31.12.2017

 

Category of shareholder

Total nos. shares held

Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a % of (A+B+C2)

(A) Promoter & Promoter Group

8,60,51,056

54.02

 

(B) Public

6,97,15,843

43.77

 

(C1) Shares underlying DRs

0.00

 

(C) Non Promoter-Non Public

35,14,240

2.21

 

Grand Total

15,92,81,139

100.00

 

 

 

Statement showing shareholding pattern of the Promoter and Promoter Group

 

Category of shareholder

Total nos. shares held

Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a % of (A+B+C2)

A1) Indian

0.00

 

Individuals/Hindu undivided Family

5,03,500

0.32

 

Hari Shanker Bhartia

3,60,885

0.23

 

Kavita Bhartia

10,285

0.01

 

Priyavrat Bhartia

3,085

0.00

 

Shamit Bhartia

1,29,245

0.08

 

Any Other (Specify)

7,85,77,176

49.33

 

Jaytee Private Limited

7,600

0.00

 

Nikita Resources Private Limited

35,04,540

2.20

 

Vam Holdings Limited

0.00

 

Jubilant Stock Holding Private Limited

2,18,71,992

13.73

 

HSB Corporate Consultants Private Limited

1,86,98,979

11.74

 

Ssb Consultants And Management Services Private Limited

2,10,07,665

13.19

 

Mav Management Advisors LLP

56,81,400

3.57

 

Jubilant Consumer Private Limited

55,67,000

3.50

 

Jubilant Advisors LLP

22,38,000

1.41

 

Sub Total A1

7,90,80,676

49.65

 

A2) Foreign

0.00

 

Individuals (NonResident Individuals/ Foreign Individuals)

13,99,935

0.88

 

Shyam Sunder Bhartia

13,99,935

0.88

 

Any Other (specify)

55,70,445

3.50

 

Torino Overseas Limited

7,70,445

0.48

 

Cumin Investments Limited

24,00,000

1.51

 

Rance Investment Holdings Limited

24,00,000

1.51

 

Sub Total A2

69,70,380

4.38

 

A=A1+A2

8,60,51,056

54.02

 

 

Statement showing shareholding pattern of the Public shareholder

 

Category & Name of the Shareholders

Total no. shares held

Shareholding % calculated as per SCRR, 1957 As a % of (A+B+C2)

B1) Institutions

0.00

 

Mutual Funds/

83,99,997

5.27

 

Motilal Oswal Mutual Fund

66,23,822

4.16

 

Alternate Investment Funds

4,45,049

0.28

 

Foreign Portfolio Investors

3,22,51,263

20.25

 

Government Pension Fund Global

28,09,661

1.76

 

East Bridge Capital Master Fund Limited

73,77,759

4.63

 

Morgan Stanley Asia (Singapore) Pte.

19,91,253

1.25

 

Financial Institutions/ Banks

4,10,349

0.26

 

Sub Total B1

4,15,06,658

26.06

 

B2) Central Government/ State Government(s)/ President of India

0.00

 

B3) Non-Institutions

0.00

 

Individual share capital upto INR 0.200 Million

1,49,36,613

9.38

 

Individual share capital in excess of INR 0.200 Million

47,78,049

3.00

 

NBFCs registered with RBI

86,394

0.05

 

Any Other (specify)

84,08,129

5.28

 

Clearing Members

2,56,813

0.16

 

Bodies Corporate

43,90,734

2.76

 

NRI

8,33,733

0.52

 

Trusts

73,006

0.05

 

HUF

4,23,598

0.27

 

JLL-Unclaimed Suspense Account

16,22,355

1.02

 

Foreign Individuals

723

0.00

 

Investor Education and Protection Fund Authority

8,07,167

0.51

 

Sub Total B3

2,82,09,185

17.71

 

B=B1+B2+B3

6,97,15,843

43.77

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is a global Pharmaceutical and Life Sciences player engaged in manufacture and supply of Generics (Including Active Pharmaceuticals Ingredients (APIs) and Solid Dosage Formulations) and Life Science Ingredients (Including Proprietary Products and Exclusive Synthesis, Nutrition Ingredients and Life Sciences Chemicals). (Registered Activity)

 

 

Products / Services :

Name and Description of main products / services

NIC Code of the Product/service

Basic Organic Chemicals

2011

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

6500 (Approximately)

 

 

Bankers :
  • Axis Bank Limited
  • Bank of Maharashtra
  • Corporation Bank
  • DBS Bank Limited
  • Export Import Bank of India
  • The Hong Kong & Shanghai Banking Corporation Limited
  • ICICI Bank Limited
  • Punjab National Bank
  • RBL Bank Limited
  • Yes Bank Limited

 

 

Facilities :

(INR In Million)

SECURED LOAN

As on

31.03.2017

As on

31.03.2016

LONG TERM BORROWING

 

 

Secured Rated Listed Non-Convertible Debentures

4930.320

0.000

Indian rupee loans

3669.200

5831.910

Other foreign currency loans

0.000

1223.590

Indian rupee loans – From other parties

1859.360

3863.730

Long term maturity of finance lease obligations

18.890

14.010

 

 

 

SHORT TERM BORROWING

 

 

Loans repayable on demand from bank

43.470

2392.810

 

 

 

Total

10521.240

13326.050

 

NOTES:

 

Nature of security of Non-current borrowings and other terms of repayment

 

(i)             Indian rupee term loans amounting to INR 3849.000 million (31 March

2016: INR 7903.920 million; 1 April 2015: INR 10181.530 million) from Axis Bank Limited, RBL Bank Limited and Non-Convertible Debentures amounting to INR 4950.000 million (31 March 2016: Nil; 1 April 2015: ` NIL), External commercial borrowings amounting to INR 1199.720 million (31 March 2016: INR 2318.750 million; 1 April 2015: INR 2968.750 million) from DBS Bank Limited, Singapore and foreign currency loans amounting to ` Nil ( 31 March 2016: INR 1325.000 million; 1 April 2015: INR 2187.500 million) from Export Import Bank of India are secured by a first pari-passu charge created/ to be created amongst the lenders by way of:

 

1)     Mortgage on the immovable fixed assets, both present and future, situate at:

(a)   Bhartiagram, Tehsil Dhanora, District Amroha, Uttar Pradesh, India, save and except the following immovable fixed assets from mortgage with effect from current year

 

i.)             Land measuring 90124.24 square meters together with all the buildings and structures thereon situated in the revenue estate of Village Naipura Khadar and Tigariya Bhoor, Tehsil Dhanora, District Amroha, Uttar Pradesh, India, being under common title deeds with other group companies;

ii.)            Land measuring 5.56 Acres OR 2.253 Hectares together with all the buildings and structures thereon situated in the revenue estate of Village Fazalpur Gosai, Tehsil Dhanora, District Amroha, Uttar Pradesh, India; and

iii.)           Leasehold Land, being plot no. A-4/2 measuring 157509 square meters, together with all the buildings and structures thereon situated in UPSIDC Industrial Area II, Gajraula, Tehsil Dhanora, District Amroha, Uttar Pradesh, India, being under common lease deed with other group companies;

 

(b)   Village Samlaya, Taluka Savli, District Vadodra, Gujarat, India, and

 

2)     Hypothecation on the entire movable fixed assets, both present and future of the Company. (1 April 2015: Indian rupee loan from Axis Bank Limited was further secured by exclusive first charge created by way of hypothecation on receivable of USD 52.50 million (Rupee equivalent converted at closing rate INR 3281.250 million) from Jubilant Generics Limited arising on account of Business Transfer Agreement)

 

(a)   (ii) Indian rupee term loan amounting to INR 1875.000 million (31 March 2016: INR 1875.000 million; 1 April 2015: INR 3000.000 million) from Housing Development Finance Corporation Limited is secured by first mortgage by way of deposit of original title deeds of specified land and buildings situated at Noida, Greater Noida, Ambernath and also at Bharuch owned by one of the subsidiaries of the Company.

 

(a)   (iii) Non-convertible debentures amounting to INR 4950.000 million (31 March 2016: Nil; 1 April 2015: Nil) is repayable in four yearly instalments from January 2019.

 

(a)   (iv) Indian rupee term loan amounting to INR 2575.000 million (31st March 2016: INR 3575.000 million repayable in ten half yearly instalments from September 2017; 1 April 2015: INR 3500.000 million repayable in fourteen half yearly instalments commencing from September 2015) from Axis Bank Limited is repayable in five half yearly instalments from March 2020.

 

(a)   (v) Indian rupee term loan amounting to INR 1274.000 million (31 March 2016: Nil; 1 April 2015: Nil) from RBL Bank Limited is repayable in nineteen quarterly instalments from June 2017.

 

(a)   (vi) Indian rupee term loan amounting to INR 1200.000 million (31 March 2016: INR 1200.000 million repayable in eight equal quarterly instalments from June 2018; 1 April 2015: INR 1800.000 million repayable in twelve equal quarterly instalments commencing from June 2017) from Yes Bank Limited has been fully repaid during the current year.

 

(a)   (vii) Indian rupee term loan amounting to INR 1128.920 million (31 March 2016: INR 1128.920 million repayable in eight quarterly instalments from June 2018; 1 April 2015: INR 1881.530 million repayable in twenty quarterly instalments commencing from June 2015) from IndusInd Bank Limited as on 31 March 2016 has been fully repaid during the current year.

 

(a)   (viii) External commercial borrowing amounting to USD 18.50 million (INR 1199.720 million) (31 March 2016: USD 35 million (INR 2318.750 million) repayable in two yearly instalments from December 2016; 1 April 2015: USD 47.5 million (INR 2968.750 million) repayable in three yearly instalments from December 2015 ) from DBS Bank Limited, Singapore is repayable in December 2017.

 

(a)   (ix) Term loan of USD 20 million (INR 1344.400 million) (31 March 2016: USD 20 million (INR 1325.000 million) repayable in one yearly instalments from May 2016; 1 April 2015: USD 35 million (INR 2187.500 million repayable in two yearly instalments from May 2015) from Export Import Bank of India has been fully repaid during the current year

 

(a)   (x) Indian rupee term loan amounting to INR 1875.000 million (31st March 2016: INR 1875.000 million repayable in five equal half yearly instalments from September 2018; 1 April 2015: INR 3000.000 million repayable in eight equal half yearly instalments commencing from March 2017.) from Housing Development Finance Corporation Limited is repayable in five equal half yearly instalments from September 2018.

 

(a)   (xi) Indian rupee term loan amounting to INR 2000.000 million from IFCI Limited (31 March 2016: INR 2000.000 million repayable in eight equal quarterly instalments from May 2018; 1 April 2015: INR 3000.000 million repayable in twelve equal quarterly instalments commencing from May 2017) has been fully repaid during the current year.

 

(a)   (xii) Loans from subsidiaries are repayable at end of five years from the date of respective disbursement.

 

(a)   (xiii) Finance lease obligations are secured by hypothecation of specific assets taken under such lease. The same are repayable within five years.

 

(a)(xiv) The term loans carry floating interest rate calculated in accordance with the terms of the arrangement which is a specified benchmark rate (reset at periodic intervals), adjusted for agreed spread. During the year ended 31 March 2017, the interest rate on Indian currency loans and foreign currency loans range from 7.95 % to 12.75% per annum (31March 2016: 10.75% to 13.25% per annum and 1 April 2015: 9.50% to 13.25% per annum) and 4.41 % to 5.18 % per annum (31 March 2016: 3.50% to 4.75% per annum and 1 April 2015: 3.50% to 4.50% per annum), respectively.

 

The composition of property, plant and equipment and current assets as mentioned above are defined in detail in the

respective financing/credit arrangements

 

Nature of security of Current borrowings and other terms of repayment

 

(b)   (i) Working capital facilities (including cash credit) sanctioned by consortium of banks and notified financial institutions are secured by a first charge by way of hypothecation, ranking pari-passu inter-se banks, of the entire book debts and receivables and inventories both present and future, of the Company wherever the same may be or be held. Other working capital loans are repayable as per terms of agreement within one year

 

(c)   (ii) Short term loans are availed in Indian rupees and in foreign currency which carry floating interest rate calculated in accordance with the terms of the arrangement which is a specified benchmark rate (reset at periodic intervals), adjusted for agreed spread. During the year ended 31 March 2017, the interest rate on Indian currency loans range from 6.09 % to 13.00% per annum (31 March, 2016: 8.75% to 14.00% and 1 April, 2015: 9.50% to 14.00% )

 

The composition of property, plant and equipment and current assets as mentioned above are defined in detail in the respective financing/credit arrangements.

 

Property, plant and equipment, inventory and other financial assets with a carrying amount of INR 14035.690 million (31 March 2016: INR 13983.930 million; 1 April 2015: INR 14293.290 million), INR 4544.400 million (31 March 2016: INR 4752.630 million; 1 April 2015: INR 5127.620 million), INR 3856.660 million (31 March 2016: INR 3412.950 million; 1 April 2015: INR 3634.660 million) respectively are provided as security against borrowing at year end.

 

Auditors :

 

Name :

B S R and Company LLP

Chartered Accountant

Address :

Building No. 10, 8th Floor, Tower – B, DLF Cyber City, Phase – II, Gurugram – 122 002, Haryana, India

Tel. No.:

91-124-2358610

Fax No.:

91-124-2358613

 

Cost Auditors:

 

Name :

J.K. Kabra and Compnay

Cost Accountants

Address :

552/1B, Arjun Street, Main Vishwas Road, Vishwas Nagar, Delhi - 100032, India

 

 

Internal Auditors :

 

Name :

Ernst and Young LLP

Address :

Golf View Corporate Tower B, Sector Road, Sector 42, Gurugram - 122 002, Haryana, India

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Key management personnel (KMP) and related entities:

  • Jubilant Enpro Private Limited
  • Jubilant Oil and Gas Private Limited
  • Jubilant Food Works Limited
  • Tower Promoters
  • Private Limited
  • B &M Hot Breads Private Limited
  • Jubilant Industries Limited
  • Jubilant Agri and Consumer Products Limited
  • Jubilant Motor Works Private Limited
  • Jubilant Fresh Private Limited
  • Priority Vendor Technologies Private Ltd (related to relatives of KMP)
  • Jubilant Industries Inc., USA.
  • Shardul Amarchand Mangaldas and Company
  • Amarchand & Mangaldas & Suresh A Shroff & Co.

 

 

Others :

  • Vam Employees Provident Fund Trust
  • Jubilant Bhartia Foundation
  • Vam Officers Superannuation Fund

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

655000000

Equity Shares

INR 1/- each

INR 655.000 Million

 

 

 

 

 

Issued, Subscribed Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

159313139

Equity Shares

INR 1/- each

INR 159.310 Million

 

 

 

 

 

Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

159281139

Equity Shares

INR 1/- each

INR 159.280 Million

 

Add: Equity shares forfeited (paid up)

 

INR 0.020 Million

 

 

 

 

 

Total

 

INR 159.300 Million

 

Movements in equity share capital:

 

Particulars

31.03.2017

Number

INR In Million

At the commencement and at the end of the year

159281139

159.280

 

 

 

 

Terms and rights attached to equity shares:

 

The Company has only one class of shares referred to as equity shares having par value of INR 1 each. Holder of each equity share is entitled to one vote per share. In the event of liquidation of the Company, the holders of equity shares will be entitled to receive any of the remaining assets of the Company, after distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by the shareholders.

 

Details of shareholders holding more than 5% shares in the Company:

 

Particulars

31.03.2017

Number

% of Holding

Jubilant Stock Holding Private Limited

159281139

13.73%

SSB Consultants and Management Services Private Limited

21007665

13.19%

HSB Corporate Consultants Private Limited

18698979

11.74%

GA Global Investments Limited

--

--

 

 

 

 

Aggregate number of shares issued for consideration other than cash:

 

Paid up capital includes, 501,364 (31 March 2016: 501,364; 1 April 2015: 501,364) equity shares of INR 1 each allotted and issued pursuant to the Scheme of Amalgamation and Demerger, to the shareholders of erstwhile Pace Marketing Specialities Limited for consideration other than cash during the year ended 31 March 2011.

 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2017

31.03.2016

31.03.2015

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

159.300

159.300

159.300

(b) Reserves & Surplus

20268.770

19978.020

19290.350

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

20428.070

20137.320

19449.650

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

13870.170

11148.310

17390.680

(b) Deferred tax liabilities (Net)

0.000

0.000

1519.700

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

506.880

454.390

438.500

Total Non-current Liabilities (3)

14377.050

11602.700

19348.880

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

1770.750

4539.420

3404.320

(b) Trade payables

4869.110

3644.870

5075.700

(c) Other current liabilities

2333.010

3222.750

3880.220

(d) Short-term provisions

133.880

145.230

716.740

Total Current Liabilities (4)

9106.750

11552.270

13076.980

 

 

 

 

TOTAL

43911.870

43292.290

51875.510

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

14173.850

14111.720

14387.760

(ii) Intangible Assets

37.630

40.660

71.500

(iii) Capital work-in-progress

646.220

348.280

200.170

(iv) Intangible assets under development

7.780

8.520

0.000

(b) Non-current Investments

16999.360

17019.040

17662.640

(c) Deferred tax assets (net)

93.990

234.740

0.000

(d)  Long-term Loan and Advances

29.540

250.730

3006.680

(e) Other Non-current assets

480.410

602.630

4.490

Total Non-Current Assets

32468.780

32616.320

35333.240

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

97.000

73.500

0.000

(b) Inventories

4544.300

4752.630

5158.600

(c) Trade receivables

3856.660

3412.950

3187.650

(d) Cash and cash equivalents

766.560

410.480

1367.350

(e) Short-term loans and advances

181.090

46.410

6769.500

(f) Other current assets

1997.480

1980.000

59.170

Total Current Assets

11443.090

10675.970

16542.270

 

 

 

 

TOTAL

43911.870

43292.290

51875.510

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

 

Income

26229.850

27909.520

31763.040

 

 

Other Income

518.950

617.410

1064.190

 

 

TOTAL                                               

26748.800

28526.930

32827.230

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

12443.450

13483.150

16631.980

 

 

Purchases of Stock-in-Trade

1196.940

1171.910

1980.530

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(570.150)

(113.920)

738.870

 

 

Excise Duty

1317.650

1348.030

0.000

 

 

Employees benefits expense

2263.080

2161.830

2408.280

 

 

Other expenses

6398.790

6735.660

7241.720

 

 

Exceptional Items

0.000

0.000

(1982.220)

 

 

TOTAL                                    

23049.760

24786.660

27019.160

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

3699.040

3740.270

5808.070

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

1742.550

2006.550

2270.960

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

1956.490

1733.720

3537.110

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION        

811.280

869.810

1074.140

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX 

1145.210

863.910

2462.970

 

 

 

 

 

Less

TAX                                                                 

353.270

133.880

411.870

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX

791.940

730.030

2051.100

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

7976.000

7761.000

6388.000

 

 

 

 

 

Less

Adjustment on account of revised useful life of fixed assets

NA

NA

86.000

 

 

 

 

 

Less

Adjustment on account of (deconsolidation)/ consolidation of Jubilant Employees Welfare Trust

NA

NA

67.000

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

375.000

0.000

0.000

 

 

Dividend

478.000

478.000

478.000

 

 

Tax on Dividend

58.000

37.000

97.000

 

BALANCE CARRIED TO THE B/S

7856.940

7976.030

7761.000

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

NA

12339.420

15648.100

 

TOTAL EARNINGS

NA

12339.420

15648.100

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

8105.740

9586.970

 

 

Stores & Spares

NA

361.650

666.990

 

 

Capital Goods

NA

7.140

34.670

 

TOTAL IMPORTS

NA

8474.530

10288.630

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

4.97

4.58

12.88

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

1337.140

2396.380

1998.390

Cash generated from operations

4245.340

1779.450

3233.560

Net cash flows from (used in) operations

4191.530

1642.980

2855.500

 

 

QUARTERLY RESULTS

 

Particulars

 

30.06.2017

1st Quarter

30.09.2017

2nd Quarter

31.12.2017

3rd Quarter

 

(Unaudited)

(Unaudited)

(Unaudited)

 

 

 

 

Net sales

15960.500

16420.400

20677.600

Total Expenditure

12584.400

13359.800

16509.200

PBIDT (Excluding Other Income)

3376.100

3060.600

4168.400

Other income

68.100

70.900

32.200

Operating Profit

3444.200

3131.500

4200.600

Interest

687.300

660.100

770.600

Exceptional Items

NA

NA

NA

PBDT

2756.900

2471.400

3430.000

Depreciation

724.800

790.100

818.200

Profit Before Tax

2032.100

1681.300

2611.800

Tax

595.000

426.600

483.400

Provisions and contingencies

NA

NA

NA

Profit after tax

1437.100

1254.700

2128.400

Extraordinary Items

NA

NA

NA

Prior Period Expenses

NA

NA

NA

Other Adjustments

NA

NA

NA

Net Profit

1437.100

1254.700

2128.400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

53.67

44.63

36.63

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

6.80

8.18

9.96

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

130.29

90.78

99.54

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.81

0.79

1.13

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.25

0.26

0.40

 

 

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.52

0.52

0.59

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.77

0.78

1.07

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.45

0.57

0.67

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.73

0.72

0.75

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

2.12

1.86

2.56

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

3.02

2.62

6.46

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

1.80

1.69

3.95

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

3.88

3.63

10.55

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.26

0.92

1.26

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.76

0.51

0.87

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.47

0.47

0.37

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

98.19

98.48

130.54

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.26

0.92

1.26

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

STOCK PRICES

 

Face Value

INR 1.00/-

Market Value

INR 850.00/-

 

 

FINANCIAL ANALYSIS

[all figures are INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

159.300

159.300

159.300

Reserves & Surplus

19290.350

19978.020

20268.770

Net worth

19449.650

20137.320

20428.070

 

 

 

 

long-term borrowings

17390.680

11148.310

13870.170

Short term borrowings

3404.320

4539.420

1770.750

Current Maturities of Long term debt

1998.390

2396.380

1337.140

Total borrowings

22793.390

18084.110

16978.060

Debt/Equity ratio

1.172

0.898

0.831

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

31763.040

27909.520

26229.850

 

 

(12.132)

(6.018)

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

31763.040

27909.520

26229.850

Profit

2051.100

730.030

791.940

 

6.46%

2.62%

3.02%

 

 

 

ABRIDGED BALANCE SHEET (CONSOLIDATED)

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

155.750

155.400

(b) Reserves & Surplus

 

34204.680

29507.160

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Non-controlling Interest

 

(392.880)

(381.330)

Total Shareholders’ Funds (1) + (2)

 

33967.550

29281.230

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

35050.330

30132.080

(b) Deferred tax liabilities (Net)

 

1863.950

1990.260

(c) Other long term liabilities

 

1958.360

1490.640

(d) long-term provisions

 

806.910

703.070

Total Non-current Liabilities (3)

 

39679.550

34316.050

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

2556.000

7489.670

(b) Trade payables

 

7494.900

6121.150

(c) Other current liabilities

 

6350.580

10717.310

(d) Short-term provisions

 

357.890

316.280

Total Current Liabilities (4)

 

16759.370

24644.410

 

 

 

 

TOTAL

 

90406.470

88241.690

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

31040.390

31147.020

(ii) Intangible Assets

 

2404.590

1586.140

(iii) Capital work-in-progress

 

2106.500

1469.160

(iv) Intangible assets under development

 

4731.330

4644.010

(v) Goodwill

 

17622.270

18311.040

(b) Non-current Investments

 

1027.140

854.310

(c) Deferred tax assets (net)

 

1418.980

844.730

(d)  Long-term Loan and Advances

 

119.270

141.960

(e) Other Non-current assets

 

454.790

490.080

Total Non-Current Assets

 

60925.260

59488.450

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

12203.990

12031.040

(c) Trade receivables

 

10053.050

9505.010

(d) Cash and cash equivalents

 

4596.310

3445.830

(e) Short-term loans and advances

 

72.400

49.620

(f) Other current assets

 

2555.460

3721.740

Total Current Assets

 

29481.210

28753.240

 

 

 

 

TOTAL

 

90406.470

88241.690

 

 

PROFIT & LOSS ACCOUNT (CONSOLIDATED)

 

 

PARTICULARS

31.03.2017

31.03.2016

 

SALES

 

 

 

 

Income

 

60063.240

58933.130

 

Other Income

 

248.580

133.720

 

TOTAL

 

60311.820

59066.850

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

 

19293.600

19950.960

 

Purchases of Stock-in-Trade

 

1853.610

1627.740

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

(1152.240)

(403.930)

 

Excise Duty

 

1448.910

1441.800

 

Employees benefits expense

 

12309.300

11250.940

 

Other expenses

 

12857.150

12596.150

 

TOTAL

 

46610.330

46463.660

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

13701.490

12603.190

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

3411.080

3713.520

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

10290.410

8889.670

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

 

2913.990

3467.440

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

 

7376.420

5422.230

 

 

 

 

 

Less

TAX (H)

 

1630.160

1554.000

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

 

5746.260

3868.230

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

36.93

25.10

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

No

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

UNSECURED LOANS:

(INR In Million)

Particulars

As on

31.03.2017

As on

31.03.2016

LONG TERM BORROWING

 

 

Indian rupee loans from subsidiaries

3392.400

215.070

 

 

 

SHORT TERM BORROWING

 

 

Loans repayable on demand from bank

1696.280

2069.110

From related parties

31.000

77.500

 

 

 

Total

5119.680

2361.680

 

 

INDEX OF CHARGE:

 

Charges Registered

SNo

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

G41996901

100092022

VISTRA ITCL (INDIA) LIMITED

10/04/2017

21/04/2017

-

4950000000.0

IL & FS FINANCIAL CENTREPLOT NO C22 G BLOCK BANDRAKURLA COMPLEX BANDRA EASTMUMBAIMa400051IN

2

G42536060

100068287

RBL BANK LIMITED

28/12/2016

21/04/2017

-

1300000000.0

SHAHUPURI,KOLHAPUR,KOLHAPURMa416001IN

3

G04442752

10563082

Axis Bank Limited

31/03/2015

31/03/2016

-

4000000000.0

B-2 & B-3, SECTOR-16NOIDANOIDAUP201301IN

4

C48105589

10557690

HOUSING DEVELOPMENT FINANCE CORPORATION LIMITED

27/03/2015

-

-

3000000000.0

RAMON HOUSE 169BACKBAY RECLAMATIONH T PAREKH MARGMUMBAIMH400020IN

5

B74167784

10343200

DBS Bank Ltd.

21/03/2012

25/04/2013

-

2504900000.0

ACTING ON BEHALF OF DBS BANK LIMITED, SINGAPORECapitol Point, Baba Kharak Singh MargNEW DELHIDL110001IN

6

C76214881

80046092

ICICI BANK LIMITED

30/03/1999

23/12/2015

-

12500000000.0

LANDMARK RACE COURSE CIRCLEALKAPURIVADODARAGJ390007IN

7

G35999192

10558963

YES BANK LIMITED

09/03/2015

12/04/2016

10/02/2017

1800000000.0

9th Floor, Nehru Centre, Discovery of IndiaDr. Annie Besant Road, WorliMumbaiMH400018IN

8

G35742642

100053705

RBL BANK LIMITED

14/09/2016

-

09/02/2017

1250000000.0

SHAHUPURI,KOLHAPUR,KOLHAPURMa416001IN

9

G31497761

10563070

INDUSIND BANK LTD.

30/03/2015

31/03/2016

22/12/2016

2000000000.0

2401 GEN THIMMAYYA ROADCONTONMENTPUNEMH411001IN

10

G28906824

10553606

IFCI LIMITED

09/03/2015

31/03/2016

30/11/2016

3000000000.0

IFCI Tower, 61Nehru PlaceNew DelhiDL110019IN

11

G07751373

10217801

EXPORT-IMPORT BANK OF INDIA

19/05/2010

20/03/2012

28/06/2016

2300000000.0

CENTRE ONE BUILDING, FLOOR 21WORD TRADE CENTRE COMPLEX, CUFFE PARADEMUMBAIMH400005IN

12

C50413012

10274305

Axis Bank Limited

08/03/2011

20/03/2012

31/03/2015

3000000000.0

B-2 & B-3, SECTOR-16NOIDANOIDAUP201301IN

13

C50990530

10303869

CENTRAL BANK OF INDIA

30/08/2011

20/03/2012

28/03/2015

2400000000.0

PRESS AREA BRANCHLINK HOUSE, 3 BAHADUR SHAH MARGNEW DELHIDL110002IN

14

C47434196

10271462

CORPORATION BANK INDUSTRIAL FINANCE BRANCH

21/02/2011

20/03/2012

16/03/2015

1000000000.0

H.T. HOUSE, 10TH FLOORK.G.MARG, CONNAUGHT PLACENEW DELHIDL110001IN

15

C47431846

10271469

CORPORATION BANK INDUSTRIAL FINANCE BRANCH

21/02/2011

20/03/2012

16/03/2015

2700000000.0

H.T. HOUSE, 10TH FLOORK.G. MARG, CONNAUGHT PLACENEW DELHIDL110001IN

16

C15953920

10229540

HOUSING DEVELOPMENT FINANCE CORPORATION LIMITED

12/07/2010

-

30/07/2014

4884000000.0

RAMON HOUSE 169BACKBAY RECLAMATIONH T PAREKH MARGMUMBAIMH400020IN

17

C15952146

10173318

HOUSING DEVELOPMENT FINANCE CORPORATION LIMITED

16/07/2009

12/07/2010

30/07/2014

4884000000.0

RAMON HOUSE 169BACKBAY RECLAMATIONH T PAREKH MARGMUMBAIMH400020IN

18

C11746229

10424562

INDIAN BANK

23/04/2013

25/04/2013

21/07/2014

1600000000.0

47-48 PRAGATI HOUSENEHRU PLACENEW DELHIDL110019IN

19

B73276529

10147320

Citi Bank N.A.

05/03/2009

31/03/2009

11/04/2013

1245000000.0

3rd Floor, Birla Towers (West Wings)25 Barakhamba Road, Connaught CircusNew DelhiDL110001IN

20

B72949621

10329564

INDIAN BANK

22/12/2011

-

29/03/2013

2700000000.0

47-48 PRAGATI HOUSENEHRU PLACENEW DELHIDL110019IN

21

B70233903

10257811

ALLAHABAD BANK

08/12/2010

20/03/2012

07/03/2013

2700000000.0

INDUSTRIAL FINANCE BRANCHFIRST FLOOR, 17 PARLIAMENT STREENEW DELHIDL110001IN

22

B24750069

10246696

The Hongkong and Shanghai Banking Corporation Limited

30/09/2010

-

08/11/2011

2000000000.0

Birla Towers25 Barakhamba RoadNew DelhiDL110001IN

23

B05177118

80061966

State Bank of India

20/04/2006

-

11/01/2011

920000000.0

Corporate Accounts Group, 12th FloorJawahar Vyapar BhawanNew DelhiDL110001IN

24

A86214517

10152086

Central Bank of India

27/03/2009

27/10/2009

26/05/2010

2500000000.0

Press Area BranchLink House, 3 Bahadur Shah Zafar MargNew DelhiDL110002IN

25

A85703155

10165544

Corporation Bank Industrial Finance Branch

17/06/2009

27/10/2009

10/05/2010

3750000000.0

1st Floor, 16/10, Main Arya Samaj RoadKarol BaghNew DelhiDL110005IN

26

A81933186

10138446

PUNJAB NATIONAL BANK

05/12/2008

-

17/03/2010

500000000.0

46-DOHIL CHAMBERSNEHRU PLACENEW DELHIDL110019IN

27

A80853633

90273438

THE WESTERN INDIA TRUSTEE AND EXCUTOR CO. LTD.

21/03/1998

08/01/2002

17/03/2010

200000000.0

16TH FLOOR; C-WING MITTAL COURTNARIMAN POINTMUMBAIMH400021IN

28

A81932147

10152546

PUNJAB NATIONAL BANK

20/02/2009

-

17/03/2010

500000000.0

46-DOHIL CHAMBERSNEHRU PLACENEW DELHIDL110019IN

29

A76333905

10136477

STATE BANK OF INDIA

22/12/2008

28/03/2009

11/01/2010

2500000000.0

CAG BRANCH, 11th & 12th FLOORJAWAHAR VYAPAR BHAWAN, 1 TOLSTOY MARGNEW DELHIDL110001IN

30

A70552617

10128963

The Hongkong and Shanghai Banking Corporation Limited

31/10/2008

31/03/2009

03/10/2009

2500000000.0

Birla House25 Barakhamba RoadNew DelhiDL110001IN

31

A66487455

10031239

BNP Paribas

27/12/2006

31/03/2009

24/07/2009

886000000.0

20, Collyer Quay No.01-01Tung CentreSingaporeNA049319SG

32

A66063397

10061387

STATE BANK OF INDIA

13/07/2007

31/03/2009

17/07/2009

3100000000.0

CAG BRANCH, 11th & 12th FLOORJAWAHAR VYAPAR BHAWAN, 1 TOLSTOY MARGNEE DELHIDL110001IN

33

A66060302

90277043

STATE BANK OF INDIA

30/03/1999

10/07/2002

15/07/2009

1610100000.0

C A G BRANCH17 BARAKHAMBA ROADNEW DELHIDL110001IN

34

A65748089

90275286

ICICI LIMITED

19/09/2000

19/09/2000

15/07/2009

38000000.0

ICICI TOWERSBANDRA KURLA COMPLEXMUMBAIMH400058IN

35

A65747099

90275052

ICICI BANK LIMITED

30/03/1999

20/12/2004

15/07/2009

3200000000.0

9-A; CONNAUGHT CIRCUSNEW DELHIDLIN

36

A66064478

90275389

BANK OF BARODA

26/03/2001

-

15/07/2009

165000000.0

CORPORATE BANKING BRANCHPARLIAMENT STREETNEW DELHIDL110001IN

37

A65394736

10134513

CORPORATION BANK

25/11/2008

28/03/2009

12/07/2009

2500000000.0

16/10, MAIN ARYA SAMAJ ROADKAROL BAGHNEW DELHIDL110005IN

38

A64332141

80046091

Export Import Bank of India

06/07/2002

24/10/2002

23/06/2009

242000000.0

World Trade CentreCuffe PAradeMumbaiMH400005IN

39

A64329998

90275779

EXPORT IMPORT BANK OF INDIA

25/08/2003

30/09/2003

23/06/2009

250000000.0

CENTRE ONE BUILDING; FLOOR 21WORLD TRADE CENTRE COMPLEX; CUFFE PARADEMUMBAIMH400005IN

40

A64331648

80046090

Export Import Bank of India

06/07/2002

24/10/2002

23/06/2009

242000000.0

World Trade CentreCuffe ParadeMumbaiMH400005IN

41

A64333081

90275592

EXPORT-IMPORT BANK OF INDIA

06/07/2002

01/04/2003

23/06/2009

242000000.0

CENTRE ONEWORLD TRADE CENTRE; CUFFE PARADEMUMBAIMH400005IN

42

A64334410

90275706

EXPORT IMPORT BANK OF INDIA

10/03/2003

-

23/06/2009

238300000.0

CENTRE ONE BUILDING; FLOOR 21WORLD TRADE CENTRE COMPLEX; CUFFE PARADEMUMBAIMH400005IN

43

A64333826

90275603

EXPORT IMPORT BANK OF INDIA

06/08/2002

24/10/2002

23/06/2009

242000000.0

CENTRE ONEWORLD TRADE CENTRE; CUFFE PARADEMUMBAIMH400005IN

44

A64924707

90275574

JAMMU & KASHMIR BANK LTD.

08/05/2002

-

15/06/2009

240000000.0

E-9; SOUTH EXTENSION-IINEW DELHIDLIN

45

A62808100

90280391

STANDARD CHARTERED BANK

15/09/2003

-

28/05/2009

150000000.0

17; SANSAD MARGNEW DELHIDL110001IN

46

A62377973

90280577

ING VYSYA BANK LTD.

25/05/2004

-

21/05/2009

300000000.0

G-35; CONNAUGHT PLACENEW DELHIDL110001IN

47

A63652861

80054312

THE PRADESHIYA INDUSTRIAL AND INVESTMENT CORPORATION OF UP LTD

04/01/1993

-

21/05/2009

3680000.0

PICUP BHAWAN ,GOMTI NAGAR,LUCKNOWUP226001IN

48

A61562104

10068426

CORPORATION BANK

17/09/2007

31/03/2009

27/04/2009

1500000000.0

16/10, MAIN ARYA SAMAJ ROADKAROL BAGHNEW DELHIDL110005IN

49

A57900268

90275984

EXPORT IMPORT BANK OF INDIA

23/09/2004

14/03/2005

09/03/2009

500000000.0

CENTRE ONEWORLD TRADE CENTRE COMPLEX; CUFFE PARADEMUMBAIMH400005IN

50

A52850500

90353945

BANK OF BARODA

13/08/2005

-

13/12/2008

2500000.0

AMBERNATH BRANCHAMBERNATHMHIN

51

A52850526

90354465

BANK OF BARODA

29/12/2005

-

13/12/2008

5000000.0

AMBERNATH BRANCHAMBERNATHMHIN

52

A38271953

90353539

BANK OF BARODA

10/03/2005

-

10/04/2008

10500000.0

AMBERNATH BRANCHAMBERNATHMHIN

53

A31675408

80018689

CORPORATION BANK

16/02/1999

-

23/01/2008

30000000.0

INDUSTRIAL FINANCE BRANCHNEW DELHIDL110001IN

54

A31676125

80018692

CORPORATION BANK

22/03/2001

-

23/01/2008

60000000.0

INDUSTRIAL FINANCE BRANCHH T HOUSE K G MARGNEW DELHIDL110001IN

55

A31672769

80018687

CORPORATION BANK

16/02/1999

-

23/01/2008

30000000.0

INDUSTRIAL FINANCE BRANCHNEW DELHIDL110001IN

56

A31671951

80018686

CORPORATION BANK

16/02/1999

-

23/01/2008

30000000.0

INDUSTRIAL FINANCE BRANCHNEW DELHIDL110001IN

57

A31675770

80018690

CORPORATION BANK

04/11/2000

-

23/01/2008

60000000.0

INDUSTRIAL FINANCE BRANCHH T HOUSE, K G MARGNEW DELHIDL110001IN

58

Y10397094

90280507

PUNJAB NATIONAL BANK

03/03/2004

14/03/2005

19/05/2006

250000000.0

NEHRU PLACENEW DELHIDL110019IN

59

Y10397224

90280637

INDIAN BANK

01/09/2004

14/03/2005

05/09/2005

0.0

P-45/90; CONNAUGHT CIRCUSNEW DLEHIDL110001IN

60

Y10392252

90275665

ICICI BANK LIMITED

26/12/2002

-

21/02/2005

0.0

ICICI TOWER; NBCC PLACEPRAGATI VIHARNEW DELHIDL110003IN

61

Y10390177

90273590

HOUSING DEVELOPMENT FINANCE CORPN. LTD.

24/10/2002

03/07/2003

21/02/2005

483700000.0

RAMON HOUSE169; BACKBAY RECLAMATIONMUMBAIMH400020IN

62

Y10391662

90275075

CANARA BANK

01/06/1999

27/01/2003

09/02/2005

168500000.0

CORPORATE SERVICE BRANCHANSAL TOWERS; 38 NEHRU PLACENEW DELHIDL110019IN

63

Y10392069

90275482

CANARA BANK

08/11/2001

27/01/2003

09/02/2005

120000000.0

CORPORATE SERVICE BRANCHANSAL TOWERS; 38 NEHRU PLACENEW DELHIDL110019IN

64

Y10392338

90275751

PUNJAB NATIONAL BANK

11/06/2003

30/09/2003

02/11/2004

0.0

NEHRU PLACENEW DELHIDL110019IN

65

Y10396952

90280365

SYNDICATE BANK

31/07/2003

30/09/2003

04/10/2004

0.0

FORTMUMBAIMH400001IN

66

Y10392312

90275725

JAMMU & KASHMIR BANK LTD.

31/03/2003

30/09/2003

07/09/2004

233500000.0

E-9; SOUTH EXTENSION-IINEW DELHIDL110001IN

67

Y10392049

90275462

INDUSTRIAL DEVELOPMENT BANK OF INDIA

20/09/2001

01/10/2001

03/06/2004

0.0

INDIAN RED CROSS SOCIETY BUILDING1; RED CROSS ROADNEW DELHIDL110001IN

68

Y10391728

90275141

INDUSTRIAL INVESTMENT BANK OF INDIA LTD.

12/11/1999

02/01/2002

02/04/2004

0.0

JEEVAN PRAKASH ; 10TH FLOOR25; KASTURBA GANDHI MARGNEW DELHIDL110001IN

69

Y10396892

90280305

ING VYSYA BANK LTD.

04/04/2003

-

29/12/2003

200000000.0

G-35; CONNAUGHT PLACENEW DELHIDL110001IN

70

Y10392141

90275554

CORPORATION BANK

22/03/2002

-

29/12/2003

44500000.0

10TH FLOOR; HINDUSTAN TIMES HOUSEKASTURBA GANDHI MARGNEW DELHIDL110001IN

71

Y10396743

90280156

CANARA BANK

04/09/2002

-

29/12/2003

130000000.0

CORPORATE SERVICE BRANCHNEHRU PLACENEW DELHIDL110019IN

72

Y10396973

90280386

ABN AMRO BANK N.V.

09/09/2003

-

29/09/2003

150000000.0

DLF CENTRESANSAD MARGNEW DELHIDL110001IN

73

Y10392283

90275696

EXPORT-IMPORT BANK OF INDIA

25/02/2003

-

08/09/2003

0.0

CENTRE ONE BUILDING; FLOOR 21WORLD TRADE CENTRE; CUFFE PARADEMUMBAIMH400005IN

74

Y10390083

90273496

IFCI LIMITED

29/05/2000

07/11/2000

14/08/2003

10500000.0

IFCI TOWER61; NEHRU PLACENEW DELHIDL110019IN

75

Y10394075

90277488

INDUSIND BANK LTD.

12/03/2003

-

07/08/2003

100000000.0

DR. GOPAL DAS BHAWAN28; BARAKHAMBA ROADNEW DELHIDL110001IN

76

Y10391807

90275220

RABO INDIA FINANCE PVT. LTD.

25/04/2000

18/12/2000

10/06/2003

0.0

1-A; JANPATHNEW DELHIDL110001IN

77

Y10393984

90277397

INDUSIND BANK

13/08/2002

-

17/04/2003

100000000.0

DR. GOPAL DAS BHAWAN28; BARAKHAMBA ROADNEW DELHIDL110001IN

 

 

CORPORATE INFORMATION

 

Subject is a public limited company domiciled in India and incorporated under the provisions of Companies Act, 1956. Its shares are listed on BSE Limited and National Stock Exchange of India Limited. The Company is a global Pharmaceutical and Life Sciences player engaged in manufacture and supply of generics (including active pharmaceutical ingredients (APls) and solid dosage formulations), specialty pharmaceuticals (sterile products) (including radiopharmaceuticals, allergy therapy products and contract manufacturing operations (CMO) of sterile injectable), and Life Science Ingredients (specialty intermediates, nutritional products and life science chemicals). It also provides Drug Discovery Solutions. The Company's strength lies in its unique offerings of pharmaceuticals and life sciences products and services across the value chain. It is well recognized as a 'Partner of Choice' by leading pharmaceuticals and life sciences companies globally.

 

 

 

STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS

FOR THE QUARTER ENDED 31ST DECEMBER 2017

(INR In Million)

 

 

Particulars

Quarter Ended

Quarter Ended

Nine Months Ended

31.12.2017

30.09.2017

31.12.2017

Unaudited

Unaudited

Unaudited

 

 

 

 

Income from Operations

 

 

 

a) Revenue from Operation

9338.300

7344.800

23785.800

b) Other Income

60.500

215.200

383.200

Total Income from Operations (net)

9398.800

7560.000

24169.000

Expenditure

 

 

 

a) Cost of materials consumed

4547.500

3689.500

11756.700

b) Purchase of stock-in-trade

526.500

261.400

1053.300

b) Changes in inventories of finished goods, work-in-progress and stock-in-trade

(367.500)

(70.300)

(280.900)

c) Excise Duty

--

2.200

366.800

d) Employee benefits expense

677.700

651.200

1910.700

e) Finance Cost

336.300

334.800

1024.200

f) Depreciation and amortisation expense

205.200

211.300

518.400

g) Other expenses

2040.800

1697.200

5230.100

Total Expenses

7966.500

6777.300

21679.900

Profit /(Loss) before tax

1432.300

782.700

2489.100

Tax expenses

453.500

782.700

2489.100

Net Profit / (Loss) after tax 

978.800

568.800

1770.500

Other Comprehensive Income

 

 

 

i)              Item that will not reclassified to profit or loss

ii)             Income tax relating to items that will not be reclassified to profit or loss

(5.500)

1.900

(5.300)

1.800

(16.200)

5.600

iii)            Items that will be reclassified to profit or loss

iv)            Income tax relating to items that will be reclassified to profit or loss

--

--

--

--

--

--

Total Other Comprehensive Income tax for the period

975.200

565.300

1759.900

Total Comprehensive Income for the period

 

 

 

Paid-up equity share capital (Face Value of Rs. 10 per share)

159.300

159.300

159.300

Other Equity

 

 

 

Basic Earning Per Share

6.15

3.57

11.12

Diluted Earning Per Share

6.15

3.57

11.12

 

 

SEGMENT WISE REVENUE, RESULTS AND CAPITAL EMPLOYED

FOR THE QUARTER ENDED 31ST DECEMBER 2017

(INR In Million)

Sr.

No.

 

 

Particulars

Quarter Ended

Quarter Ended

Nine Months Ended

31.12.2017

30.09.2017

31.12.2017

Unaudited

Unaudited

Unaudited

A

Segment Revenue

 

 

 

 

a) Pharmaceuticals

43.000

49.500

134.200

 

b) Life Sciences Ingredients

9295.300

7295.300

23651.600

 

Total

9338.300

7344.800

23785.800

 

 

 

 

 

 

Less: Inter Segment revenue

--

--

--

 

Total revenue from operations

9338.300

7344.800

23785.800

 

a) Pharmaceuticals

43.000

49.500

134.200

 

b) Life Sciences Ingredients

9295.300

7295.300

23651.600

 

 

 

 

 

B

Segment Results

 

 

 

 

Profit/(Loss) (Before Tax and Interest)

For each Segment

 

 

 

 

a) Pharmaceuticals

(67.000)

(68.700)

(221.200)

 

b) Life Sciences Ingredients

1931.500

1098.100

3793.800

 

Total

1864.500

1029.400

3572.600

 

 

 

 

 

 

Less: Interest (Finance cost)

336.300

334.800

1024.200

 

Add :Exceptional items and un-allocable expenditure

95.900

(88.100)

59.300

 

Total Profit Loss Before Taxation

1432.300

782.700

2489.100

 

 

 

 

 

C

Segment Assets

 

 

 

 

a) Pharmaceuticals

47.600

50.300

47.600

 

b) Life Sciences Ingredients

26868.700

24578.100

26868.700

 

c) Unallocable corporate assets (excluding deferred tax assets)

19118.700

18858.100

19118.700

 

Total Segment Assets

46035.00

43486.500

46035.000

 

 

 

 

 

D

Segment Liabilities

 

 

 

 

a) Pharmaceuticals

74.700

74.700

74.700

 

b) Life Sciences Ingredients

7727.200

5521.000

7727.200

 

c) Unallocable corporate assets (excluding deferred tax assets)

849.400

561.200

849.400

 

Total Segment Liabilities

8651.300

6156.900

8651.300

 

 

 

 

 

C

Capital Employed

(Segment Assets - Segment Liabilities)

 

 

 

 

a) Pharmaceuticals

(27.100)

(26.400)

(27.100)

 

b) Life Sciences Ingredients

19141.500

19057.100

19141.500

 

c) Unallocable corporate assets

18269.300

18296.900

18269.300

 

Total

37383.700

37329.600

37383.700

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Equipment

·         Furniture and Fixture

·         Vehicles

·         Office Equipment

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 
Unit

INR

US Dollar

1

INR 65.23

UK Pound

1

INR 89.71

Euro

1

INR 79.50

 

 

INFORMATION DETAILS

 

Information Gathered by :

SAV

 

 

Analysis Done by :

NYT

 

 

Report Prepared by :

JYO

 

 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.